लोड हो रहा है...

A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia.

The side effect profiles and lipid lowering efficacy of nicotinic acid (1 g three times daily) and its analogue acipimox (250 mg three times daily) in type 2b hyperlipidaemia were compared in a double-blind placebo controlled study. In the nicotinic acid group (n = 7) at 12 weeks there were signific...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: O'Kane, M J, Trinick, T R, Tynan, M B, Trimble, E R, Nicholls, D P
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 1992
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC1381338/
https://ncbi.nlm.nih.gov/pubmed/1576071
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!